(Q44335711)

2 December 2017

title

Expression of cell cycle regulatory proteins in breast carcinomas before and after preoperative chemotherapy (English)

1 reference

preoperative chemotherapy

2 December 2017

main subject

1 reference

Gudrun Pohl

1

1 reference

2 December 2017

Margaretha Rudas

2

1 reference

2 December 2017

Susanne Taucher

3

1 reference

2 December 2017

Thomas Stranzl

4

1 reference

2 December 2017

Günther G Steger

5

1 reference

2 December 2017

Raimund Jakesz

6

1 reference

2 December 2017

Robert Pirker

7

1 reference

2 December 2017

Martin Filipits

8

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Breast Cancer Research and Treatment

2 December 2017

published in

1 reference

2 December 2017

volume

78

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

97-103

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1022165715043

2 December 2017

exact match

0 references

cites work

Correlation of pretreatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Preoperative chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Cell-cycle arrest versus cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Prognostic and predictive value of p53 and p21 in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

p(21WAF1/CIP1) expression in breast cancers: associations with p53 and outcome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Cyclin D3 expression in normal, reactive and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Differential roles of p21(Waf1) and p27(Kip1) in modulating chemosensitivity and their possible application in drug discovery studies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

How the cyclin became a cyclin: regulated proteolysis in the cell cycle

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Cell cycle modifications of breast cancers during neoadjuvant chemotherapy: a flow cytometry study on fine needle aspirates

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1022165715043

7 January 2021

Identifiers

DOI

10.1023/A:1022165715043

1 reference

Dimensions Publication ID

2 December 2017

1017029158

0 references

1 reference